The role of autophagy in hypoxia-induced radioresistance

Hill, Rhianna Mae; Fok, Matthew; Grundy, Gabrielle; Parsons, Jason Luke; Rocha, Sonia

doi:10.1016/j.radonc.2023.109951

Radiotherapy and Oncology

2023

DOI: 10.1016/j.radonc.2023.109951

|View full text |Cite

The role of autophagy in hypoxia-induced radioresistance

Rhianna Mae Hill,

Matthew Fok,

Gabrielle Grundy

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 112 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies

Skrzeszewski,

Maciejewska,

Kobza

et al. 2024

Biochemical Pharmacology

View full text Add to dashboard Cite

Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies

Skrzeszewski,

Maciejewska,

Kobza

et al. 2024

Biochemical Pharmacology

View full text Add to dashboard Cite

Targeting a mTOR/autophagy axis: a double-edged sword of rapamycin in spontaneous miscarriage

Li,

Shen,

Cao

et al. 2024

Biomedicine & Pharmacotherapy

View full text Add to dashboard Cite

CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/Caspase 9/Caspase 3 pathway

Wang,

Zhang,

Huang

et al. 2024

International Immunopharmacology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The role of autophagy in hypoxia-induced radioresistance

Cited by 3 publications

References 112 publications

Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies

Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies

Targeting a mTOR/autophagy axis: a double-edged sword of rapamycin in spontaneous miscarriage

CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/Caspase 9/Caspase 3 pathway

Contact Info

Product

Resources

About